Table 4.
Measurement of liver function in the diabetic (STZ) and Spirulina (Spi) extract-treated serum.
| Total Protein (g/dL) | Albumin (g/dL) | GOT (IU/L) | GPT (IU/L) | ALP (U/L) | γ-GT (IU/L) | |
|---|---|---|---|---|---|---|
| Control | 6.0 ± 0.02 | 4.5 ± 0.03 | 151.8 ± 2.63 | 53.4 ± 3.07 | 955.4 ± 34.35 | 2.0 ± 0.00 |
| Spi | 6.2 ± 0.10 | 4.4 ± 0.04 | 121.7 ± 6.53 | 54.4 ± 2.20 | 856.8 ± 31.42 | 2.0 ± 0.40 |
| STZ (2 weeks) | 5.6 ± 0.05 | 3.9 ± 0.04 | 325.0 ± 17.68 | 163.7 ± 2.62 | 3422.0 ± 77.89 | 2.0 ± 0.00 |
| Spi + STZ | 5.6 ± 0.05 | 3.9 ± 0.05 | 212.7 ± 8.37 a | 166.3 ± 15.11 | 2159.3 ± 223.77 a | 2.0 ± 0.00 |
| STZ (4 weeks) | 5.4 ± 0.05 | 3.7 ± 0.06 | 367.7 ± 1.31 | 358.0 ± 44.25 | 3725.6 ± 154.05 | 11.3 ± 1.43 |
| STZ + Spi | 5.4 ± 0.05 | 3.6 ± 0.03 | 232.0 ± 23.90 b | 208.7 ± 7.96 | 2798.0 ± 140.70 b | 2.3 ± 0.20 b |
Values are expressed as means ± SEM for six animals in each group. a p < 0.01, significant difference between the STZ (2 weeks)-treated and the Spi extract-pretreated group (Spi + STZ). b p < 0.01, significant difference between the STZ (4 weeks)-treated and the Spi extract-post treated group (STZ + Spi).